Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
Chang Liu, Ying Jin, Zhimin Fan
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics
Dolly Sharma, Mamta Singh, Reshma Rani
Seminars in Cancer Biology (2022) Vol. 87, pp. 184-195
Closed Access | Times Cited: 140
Targeting the Warburg Effect in Cancer: Where Do We Stand?
Ignasi Barba, Laura Carrillo-Bosch, Joan Seoane
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3142-3142
Open Access | Times Cited: 44
miRNAs in pancreatic cancer progression and metastasis
Ellie T. Y. Mok, Jessica L. Chitty, Thomas R. Cox
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 3, pp. 163-186
Open Access | Times Cited: 19
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer
Roberto Ronca, Claudiu T. Supuran
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189120-189120
Open Access | Times Cited: 16
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 13
Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers
Annalisa Comandatore, Marika Frańczak, Ryszard T. Smoleński, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 93-100
Open Access | Times Cited: 61
Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes
Michele Coluccia, Valeria Parisse, Paolo Guglielmi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114801-114801
Closed Access | Times Cited: 54
Functional Role of Mitochondrial DNA in Cancer Progression
Yang-Hsiang Lin, Siew‐Na Lim, Cheng‐Yi Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1659-1659
Open Access | Times Cited: 44
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy
Davide Gnocchi, Carlo Sabbà, Mara Massimi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3710-3710
Open Access | Times Cited: 24
Recent Advances in Bioconjugated Transition Metal Complexes for Cancer Therapy
Enrica Bortolamiol, Fabiano Visentin, Thomas Scattolin
Applied Sciences (2023) Vol. 13, Iss. 9, pp. 5561-5561
Open Access | Times Cited: 21
The Warburg effect on radioresistance: Survival beyond growth
Hyunkoo Kang, Byeongsoo Kim, Junhyeong Park, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188988-188988
Closed Access | Times Cited: 20
Targeting hypoxic and acidic tumor microenvironment by nanoparticles: A review
Mohamed J. Saadh, Mohammed Ahmed Mustafa, Laith Yassen Qassem, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105660-105660
Closed Access | Times Cited: 6
Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
Siuli Shaw, Subrata K. Pore, D.-M. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189261-189261
Closed Access
Soy Isoflavone Genistein Enhances Tamoxifen Sensitivity in Breast Cancer via microRNA and Glucose Metabolism Modulation
Jessica Shpigel, Eliete Luciano, Blessing Ukandu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 733-733
Open Access
Effect of basic fibroblast growth factor on hypoxia-inducible factor (HIF)-1α expression (Exp) and HIF-1 transcription in breast Cancer cell through PI-3 K Akt signaling
Cheng‐Cai Zhang, Jinxia Yu, Shuaifeng Li
Cytokine (2025) Vol. 187, pp. 156859-156859
Closed Access
Recent advances in chemodynamic nanotherapeutics to overcome multidrug resistance in cancers
Wenjia Xu, Min Wang, Xinyu Liu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117901-117901
Closed Access
Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas
Francesca Persano, Giuseppe Gigli, Stefano Leporatti
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3360-3360
Open Access | Times Cited: 35
Correlation between the Warburg effect and progression of triple-negative breast cancer
Shaojun Liu, Yuxuan Li, Meng Yuan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 19
Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
Katherine E. Pendleton, Karen Wang, Gloria V. Echeverria
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 18
Glucose Transporter 1-Mediated Transcytosis of Glucosamine-Labeled Liposomal Ceramide Targets Hypoxia Niches and Cancer Stem Cells to Enhance Therapeutic Efficacy
Lu-Yi Yu, Pei‐Wei Shueng, Hsin‐Cheng Chiu, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13158-13175
Closed Access | Times Cited: 15
Betulinic acid in the treatment of breast cancer: Application and mechanism progress
Huijuan Mu, Yuli Sun, Bo Yuan, et al.
Fitoterapia (2023) Vol. 169, pp. 105617-105617
Closed Access | Times Cited: 15
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
Andrea Cunha, Patrícia Silva, Bruno Sarmento, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2610-2610
Open Access | Times Cited: 15
The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contexts
Nadin H. Sarg, Dana M. Zaher, Nour N. Abu Jayab, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116307-116307
Closed Access | Times Cited: 5
Comprehensive Insights into Oral Squamous Cell Carcinoma: Diagnosis, Pathogenesis, and Therapeutic Advances
Dharshini Jagadeesan, Kathiresan V. Sathasivam, Neeraj Kumar Fuloria, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155489-155489
Closed Access | Times Cited: 5
Galactose engineered nanocarriers: Hopes and hypes in cancer therapy
Mahak Fatima, Ritu Karwasra, Waleed Hassan Almalki, et al.
European Polymer Journal (2022) Vol. 183, pp. 111759-111759
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top